Last week, word came out that Haven, the disruptive healthcare collaboration between Amazon, Berkshire Hathaway and JP Morgan Chase was not going to disrupt anything. Three years after its inception, the project was shutting down. Despite everything else going on in healthcare, the announcement made pretty big headlines just as it had when it was launched. Why was it big news? And is there some larger lesson for healthcare to take from the failed project? Maybe the first question is, is Haven actually a failed project? What insights should we take from the whole three-year cycle? Over the course of a couple of days, we talked with several of our friends who work in different areas of healthcare to get their take: Lisa Bielamowicz, MD, president and co-founder of Gist Healthcare and a highly experienced radiologist; Marcus Whitney, partner at Jumpstart Health Investors with a particular interest in the role of technology and innovation in healthcare; Bryan Vartabedian, Director of Community Medicine, Texas Childrens Hospital The Woodlands and author of the 33 charts newsletter that explores medicine and technology (33charts.com); David Pate, MD, JD, the former CEO of St. Luke’s Health System in Boise and of-counsel at Jarrard.
